SD Express Delivers New Gigabyte Speeds for SD Memory Cards
19.5.2020 15:00:00 EEST | Business Wire | Press release
The SD Association announced today the SD 8.0 Specification for SD Express memory cards receives even faster transfer speeds by using the popular PCI Express® (PCIe®) 4.0 specification delivering a maximum of nearly 4 gigabytes per second (GB/s) data transfer rate. These full sized cards continue to use the NVMe Express™ (NVMe™) upper layer protocol enabling advanced memory access mechanism. As always SD Express memory cards using SD 8.0 specification maintain backward compatibility.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200519005027/en/
SD Express memory card types (Photo: Business Wire)
“SD Express’ use of even faster PCIe and NVMe architectures to deliver faster transfer speeds creates more opportunities for devices to use SD memory cards,” said Mats Larsson, Senior Market Analyst at Futuresource. “This combination of trusted and well-known technologies makes it easier for future product designs to leverage the benefits of removable storage in new ways.”
SD Express gigabyte speeds bring new storage opportunities for devices with demanding performance levels, across a variety of industries. The cards can move large amounts of data generated by data-intense wireless or wired communication, super-slow motion video, RAW continuous burst mode and 8K video capture and playback, 360 degree cameras/videos, speed hungry applications running on cards and mobile computing devices, ever evolving gaming systems, multi-channel IoT devices and automotive to name a few. SD Express will be offered on SDHC, SDXC and SDUC memory cards.
“By dramatically increasing the speeds for SD Express we’re giving device manufacturers and system developers more storage choices,” said Hiroyuki Sakamoto, SDA president. “SD 8.0 may open even more opportunities for extra high performance solutions using removable memory cards.”
“PCI-SIG® is pleased to see that SDA is continuing to adopt even faster PCIe technology configurations using PCIe 4.0 interface and dual lanes for one of the top leading removable memory cards – SD,” said Al Yanes, PCI-SIG president and chairman. “PCIe specification conformance tests are available today by major test vendors, offering a significant advantage for any new PCIe technology adopter.”
“NVMe is the industry-recognized performance SSD interface from the client to the datacenter, shipping in millions of units,” said Amber Huffman, NVM Express™ Inc. president. “Consumers will benefit by SD Association continuing the adoption of the NVMe base specification for their latest SD Express cards.”
SD Express uses the well-known PCIe 4.0 specification and the latest NVMe specification (up to version 1.4) defined by PCI-SIG and NVM Express, respectively. SD 8.0 specification provides two transfer speed options for SD Express memory cards. The two transfer speeds are accomplished by supporting either PCIe 3.0 x2 or PCIe 4.0 x1 architectures with up to ~2GB/s and with PCIe 4.0 x2 technology with up to 4GB/s. SD Express cards offering PCIe 4.0 x1 architecture use the same form factor as defined for SD 7.0 specification cards with a second row of pins to deliver transfer speeds up to 2 GB/s. SD Express cards supporting dual PCIe lanes (PCIe 3.0 x2 or PCIe 4.0 x2 technologies) have three rows of pins.
The SDA makes adoption of SD Express easy allowing companies to use existing test equipment and saving in product development costs. The SD 8.0 specification continues giving system developers access to PCIe and NVMe technologies, such as Bus Mastering, Multi Queue (without locking mechanism) and Host Memory Buffer.
Two revised white papers, “SD Express Cards with PCIe and NVMe Interfaces,” and “SD Express and microSD Express Memory Cards: The Best Choice for Your Future Product Designs” provide an in-depth look at the opportunities created by SD Express. More information is available on our website.
Visit the SDA Virtual Tradeshow to learn more about SD Express solutions offered by our members.
SD Association
The SD Association is a global ecosystem of nearly 900 technology companies charged with setting interoperable SD standards. The Association encourages the development of consumer electronic, wireless communication, digital imaging and networking products that utilize market-leading SD technology. The SD standard is the number one choice for consumers and has earned more than 80 percent of the memory card market with its reliable interoperability and its easy-to-use format. Today, smart phones, tablets, drones, IoT devices, HDTVs, audio players, automotive systems, computers, digital cameras and digital video cameras feature SD interoperability. For more information about SDA or to join, please visit the Association’s website, https://www.sdcard.org .
SD Logos are trademarks licensed by SD-3C LLC.
PCI-SIG
PCI-SIG is the consortium that owns and manages PCI specifications as open industry standards. The organization defines industry standard I/O (input/output) specifications consistent with the needs of its members. Currently, PCI-SIG is comprised of nearly 800 industry-leading member companies. To learn more about PCI-SIG, and for a list of the Board of Directors, visit www.pcisig.com. PCI Express® is a registered trademark of PCI-SIG.
About NVM Express, Inc.
With more than 100 members, NVM Express is a non-profit organization focused on enabling broad ecosystem adoption of high performance and low latency non-volatile memory (NVM) storage through a standards-based approach. The organization offers an open collection of NVM Express (NVMe™) specifications and information to fully expose the benefits of non-volatile memory in all types of computing environments from mobile to data center. NVMe-based specifications are designed from the ground up to deliver high bandwidth and low latency storage access for current and future NVM technologies. For more information, visit http://www.nvmexpress.org.
PCIe® - PCI Express, is a standard developed by PCI-SIG® and PCIe® is a trademark owned by PCI-SIG.
NVMe™ - NVM ExpressTM, is a standard developed by NVM Express Inc. and NVMe™ is a trademark owned by NVM Express Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200519005027/en/
Contact information
Kevin Schader
SD Association
1.925.275.6670
media@sdcard.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom